The 15 references in paper V. Brzhezovsky, M. Lomaya V., T. Aketova A., В. Бржезовский Ж., М. Ломая В., Т. Акетова А. (2015) “ИСПОЛЬЗОВАНИЕ ФАКТОРОВ ПРОГНОЗА В ВЫБОРЕ ТАКТИКИ ЛЕЧЕНИЯ РАКА ЩИТОВИДНОЙ ЖЕЛЕЗЫ // USE OF PREDICTORS TO CHOOSE TREATMENT POLICY FOR THYROID CANCER” / spz:neicon:ogsh:y:2014:i:1:p:11-14

1
Bilimoria K.Y., Bentrem D.J., Linn J.G. et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 2007;142(6):906–13 [discussion 913. e1–2].
(check this in PDF content)
2
Lin J.D., Chen S.T., Hsueh C., Chao T.C. A 29-year retrospective review of papillary thyroid cancer in one institution. Thyroid 2007 Jun;17(6):535–41.
(check this in PDF content)
3
Mazeh H., Samet Y., Hochstein D. et al. Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy. Am J Surg 2011 Jun; 201(6):770–5.
(check this in PDF content)
4
Ibrahimpasic T., Nixon I.J., Palmer F.L. et al. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer – is there a need for radioactive iodine therapy? Surgery 2012;152(6):1096–105.
(check this in PDF content)
5
Almeida J.P., Sanabria A.E., Lima E.M., Kowalski L. et al. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck 2011;33(5):686–90.
(check this in PDF content)
6
Nixon I.J., Ganly J., Patel S.G. et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 2012;151(4):571–9.
(check this in PDF content)
7
Пачес А.И. Опухоли головы и шеи. Клиническое руководство. М., 2013. 475 с.
(check this in PDF content)
8
Романчишен А.Ф. Клиническое обоснование показаний к оперативному лечению заболеваний щитовидной железы. Вестник хирургии 1994;1–2:3–6.
(check this in PDF content)
9
Sosa J.A., Bowman H.M., Tielsch J.M. et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998;228(3):320–30.
(check this in PDF content)
10
Shah J.P., Loree T.R., Dharker D. et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164(6):658–61.
(check this in PDF content)
11
Nixon I.J., Shah J.P. Well differentiated thyroid cancer: are we over treating our patients? Eur J Surg Oncol 2014 Feb;40(2):129–32.
(check this in PDF content)
12
Haymart M.R., Benerjee M., Stewart A.K. et al. Use of radioactive iodine for thyroid cancer. JAMA 2011;306(7):721–8.
(check this in PDF content)
13
Trovisco V., Soares P., Sobrinho-Simões M. B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas. Hum Pathol 2006 Jul;37(7):781–6.
(check this in PDF content)
14
Wang W., Zhao W., Wang E.U. et al. Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol 2012 Jan;19(1):31–36.
(check this in PDF content)
15
Danilovic D.L., Lima E.U., Domingues R.B. et al. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma. Eur J Endocrinol 2014;170(4):619–25.
(check this in PDF content)